Abpro Holdings, Inc.
ABPWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001893219
No open-market purchases or sales by Abpro Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesABPO
Q2 2025 vs. Q1 2025
How the institutions holding Abpro Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 27 | 29 | +2 |
| Shares | 7.51M | 8.13M | +623.2K (+8.3%) |
| Value | $243.4K | $197.8K | −$45.6K (−18.7%) |
New holders (4)
Institutions that held Abpro Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diametric Capital, LP | 358,427 | $8.26K | 0.00% |
| Toronto Dominion Bank | 274,198 | $5.68K | 0.00% |
| UBS Group AG | 1,130 | $19 | 0.00% |
| HRT Financial LP | 14,406 | $0 | 0.00% |
Sold out (2)
Institutions that held Abpro Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Highbridge Capital Management LLC | – | $17.3K |
| Yakira Capital Management, Inc. | 50,000 | $1.27K |